282 related articles for article (PubMed ID: 12614448)
21. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
Dubertret L; Murrieta Aguttes M; Tonet J
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
[TBL] [Abstract][Full Text] [Related]
22. [Diagnostic and physiopathological innovations related to chronic urticaria].
Bérard F; Boulinguez S
Ann Dermatol Venereol; 2010 May; 137(5 Suppl 1):24-7. PubMed ID: 20510177
[No Abstract] [Full Text] [Related]
23. [Chronic urticaria. Clinical evolution, autologous serum test, count and activation of basophils].
Galassi N; Riera N; Rey G; Bracco MM; Malbrán A
Medicina (B Aires); 2003; 63(1):15-20. PubMed ID: 12673955
[TBL] [Abstract][Full Text] [Related]
24. Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria.
Engin B; Ozdemir M
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):481-6. PubMed ID: 18081753
[TBL] [Abstract][Full Text] [Related]
25. In vivo and ex vivo inhibitory effects of loratadine on histamine release in patients with allergic rhinitis.
Miadonna A; Cottini M; Milazzo N; Tosi D; Danzig M; Tedeschi A
Allergy; 1998 Dec; 53(12):1183-8. PubMed ID: 9930595
[TBL] [Abstract][Full Text] [Related]
26. Secretion of cytokines, histamine and leukotrienes in chronic urticaria.
Ferrer M; Luquin E; Sanchez-Ibarrola A; Moreno C; Sanz ML; Kaplan AP
Int Arch Allergy Immunol; 2002 Nov; 129(3):254-60. PubMed ID: 12444324
[TBL] [Abstract][Full Text] [Related]
27. Significant correlation between the CD63 assay and the histamine release assay in chronic urticaria.
Szegedi A; Irinyi B; Gál M; Hunyadi J; Dankó K; Kiss E; Sipka S; Szegedi G; Gyimesi E
Br J Dermatol; 2006 Jul; 155(1):67-75. PubMed ID: 16792754
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of autoimmune activation of basophils in chronic urticaria.
Kikuchi Y; Kaplan AP
J Allergy Clin Immunol; 2001 Jun; 107(6):1056-62. PubMed ID: 11398085
[TBL] [Abstract][Full Text] [Related]
29. Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria.
Vonakis BM; Vasagar K; Gibbons SP; Gober L; Sterba PM; Chang H; Saini SS
J Allergy Clin Immunol; 2007 Feb; 119(2):441-8. PubMed ID: 17125820
[TBL] [Abstract][Full Text] [Related]
30. Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticaria.
Rauber MM; Pickert J; Holiangu L; Möbs C; Pfützner W
Allergy; 2017 Dec; 72(12):1904-1911. PubMed ID: 28585360
[TBL] [Abstract][Full Text] [Related]
31. Influence of desloratadine on oxidative stress markers in patients with chronic idiopathic urticaria.
Cassano N; Raho G; Filieri M; D'Argento V; Amoruso A; Filotico R; Vena GA
Int J Dermatol; 2006 Apr; 45(4):394-6. PubMed ID: 16650165
[TBL] [Abstract][Full Text] [Related]
32. Evidence of in vivo basophil activation in chronic idiopathic urticaria.
Vasagar K; Vonakis BM; Gober LM; Viksman A; Gibbons SP; Saini SS
Clin Exp Allergy; 2006 Jun; 36(6):770-6. PubMed ID: 16776678
[TBL] [Abstract][Full Text] [Related]
33. Pathogenesis of chronic urticaria.
Kaplan AP; Greaves M
Clin Exp Allergy; 2009 Jun; 39(6):777-87. PubMed ID: 19400905
[TBL] [Abstract][Full Text] [Related]
34. Basophil markers for identification and activation in the indirect basophil activation test by flow cytometry for diagnosis of autoimmune urticaria.
Kim Z; Choi BS; Kim JK; Won DI
Ann Lab Med; 2016 Jan; 36(1):28-35. PubMed ID: 26522756
[TBL] [Abstract][Full Text] [Related]
35. Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD 63.
De Swerdt A; Van Den Keybus C; Kasran A; Cadot P; Neyens K; Coorevits L; Kochuyt AM; Degreef H; Ceuppens JL
J Allergy Clin Immunol; 2005 Sep; 116(3):662-7. PubMed ID: 16159640
[TBL] [Abstract][Full Text] [Related]
36. Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study.
Grob JJ; Auquier P; Dreyfus I; Ortonne JP
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):87-93. PubMed ID: 18181978
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the in vivo autologous skin test with in vitro diagnostic tests for diagnosis of chronic autoimmune urticaria.
Altrich ML; Halsey JF; Altman LC
Allergy Asthma Proc; 2009; 30(1):28-34. PubMed ID: 19026096
[TBL] [Abstract][Full Text] [Related]
38. Treatment of chronic autoimmune urticaria with omalizumab.
Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of the H1 antagonist loratadine on histamine release from human basophils.
Miadonna A; Milazzo N; Lorini M; Marchesi E; Tedeschi A
Int Arch Allergy Immunol; 1994 Sep; 105(1):12-7. PubMed ID: 7522069
[TBL] [Abstract][Full Text] [Related]
40. Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria.
Gyimesi E; Sipka S; Dankó K; Kiss E; Hídvégi B; Gál M; Hunyadi J; Irinyi B; Szegedi A
Br J Dermatol; 2004 Aug; 151(2):388-96. PubMed ID: 15327546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
